All Comparisons/CellmatiQ vs CoTreat AI

VNDRIQ — Vendor Comparison

CellmatiQ vs CoTreat AI

Side-by-side comparison of BAA status, PHI exposure, AI training risk, HIPAA suitability, and VNDRIQ governance scores.

CellmatiQ35
CoTreat AI47

CellmatiQ

Dental Imaging AI

Verification pending

CoTreat AI

Dental Imaging AI

Verification pending

VNDRIQ Scores

35

Overall

Privacy Score36
Governance Score37
Healthcare Readiness35
AI Risk Score30

47

Overall

Privacy Score36
Governance Score55
Healthcare Readiness42
AI Risk Score55

Approval Tier

Restricted / Review Required
Conditional / Verify BAA

BAA Status

No public Business Associate Agreement (BAA) was identified in the search results; the company primarily emphasizes EU CE certification and GDPR compliance.
Not explicitly stated; as an Australian-based company, verification of US HIPAA compliance and BAA availability is required before use with US PHI.

PHI Exposure Risk

High
High

AI Training Risk

High
Medium

HIPAA Risk Level

High
High

Review Frequency

Quarterly

Quarterly

Recommended Use

Automated cephalometric landmark identification and diagnostic support for dental pathologies in clinical settings.

Dental treatment planning, radiograph analysis, and practice management optimization through automated detection of treatment opportunities.

Restrictions

Primarily certified for the EU market (CE mark); FDA clearance for the US market is not confirmed in available documentation.

Clinical decisions must be verified by a dental professional; primarily integrated with Australian and UK-based practice management systems.

Executive Summary

CellmatiQ

Dental Imaging AI

CellmatiQ is classified as Restricted / Review Required with a BAA status of No public Business Associate Agreement (BAA) was identified in the search results; the company primarily emphasizes EU CE certification and GDPR compliance.. PHI exposure is rated High and AI training risk is High. Automated cephalometric landmark identification and diagnostic support for dental pathologies in clinical settings.

36

Privacy

37

Governance

35

Healthcare

30

AI Risk

CoTreat AI

Dental Imaging AI

CoTreat AI is classified as Conditional / Verify BAA with a BAA status of Not explicitly stated; as an Australian-based company, verification of US HIPAA compliance and BAA availability is required before use with US PHI.. PHI exposure is rated High and AI training risk is Medium. Dental treatment planning, radiograph analysis, and practice management optimization through automated detection of treatment opportunities.

36

Privacy

55

Governance

42

Healthcare

55

AI Risk

Recommended For

CellmatiQ

Automated cephalometric landmark identification and diagnostic support for dental pathologies in clinical settings.

Currently under review — not recommended for active PHI deployment

CoTreat AI

Dental treatment planning, radiograph analysis, and practice management optimization through automated detection of treatment opportunities.

Organizations able to execute BAA prior to deployment

IT teams with capacity to verify data handling agreements

Governance Considerations

CellmatiQ

Verify model training opt-out clauses before deployment.

PHI exposure is elevated. Review data flow documentation.

Quarterly reviews are required — establish internal review cadence.

Restrictions noted: Primarily certified for the EU market (CE mark); FDA clearance for the US market is not confirmed in available documentation.

CoTreat AI

PHI exposure is elevated. Review data flow documentation.

Quarterly reviews are required — establish internal review cadence.

Restrictions noted: Clinical decisions must be verified by a dental professional; primarily integrated with Australian and UK-based practice management systems.

Questions to Ask Before Approval

01

Has the vendor executed a Business Associate Agreement (BAA) with your organization?

02

Does the vendor use customer data to train AI models? Can you opt out?

03

Where is PHI stored, processed, and transmitted?

04

What data retention and deletion policies apply to your PHI?

05

Has the vendor undergone a third-party HIPAA or SOC 2 audit?

06

What is the vendor's incident response and breach notification process?

07

Does the vendor offer audit logging for PHI access?

08

What subprocessors have access to PHI through this vendor?

Request Vendor Evaluation

Get a structured risk assessment for any vendor.

Request Benchmark Report

Compare vendors across your full stack.

Book Governance Assessment

Talk to a VNDRIQ governance specialist.